An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, by using drugs already approved by the FDA for unrelated conditions.
Their research suggests that repurposing existing medications can reduce harmful immune responses associated with nanoparticles. These ultra-small particles are designed to deliver treatments with precision but, in some cases, the immune system can react adversely.
“Nanoparticles are powerful tools in medicine, but the body often recognizes them as threats,” said Dmitri Simberg, Ph.D., co-director and professor at the Colorado Center for Nanomedicine and Nanosafety at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz and lead author of the study.
“We found that certain existing drugs used for immune-related conditions can help mitigate these reactions.”
When introduced into the body for therapy or imaging, nanoparticles can trigger inflammation and other immune-related side effects. This occurs when the immune system, particularly the complement system, a group of blood proteins responsible for detecting potential threats, mistakenly targets helpful nanoparticles.
“This system is crucial for fighting infections, but it can become overactive in response to nanomedicine,” Simberg explained.
These overreactions may cause symptoms such as skin rashes, respiratory distress, cardiovascular problems or serious anaphylactic reactions. To address this, the team tested immune-modulating compounds that inhibit complement activation, aiming to reduce immune attacks on nanoparticles without broadly weakening the immune system.
Among the drugs tested in blood samples, iptacopan, currently approved to treat certain rare blood, nerve, and kidney disorders, was notably effective in blocking complement activity and minimizing adverse effects.
“We were impressed by how well iptacopan performed in preclinical animal models and some human samples,” said Simberg. “It not only reduced immune responses but also prevented more severe symptoms.”
The researchers also noted considerable variability in how individuals respond to nanoparticle-based treatments, often depending on specific ingredients used. This highlights the importance of personalized approaches to nanomedicine.
“We still need to understand which patients are at higher risk of allergic or inflammatory reactions, in order to apply immune-modulating drugs during nanomedicine treatment,” Simberg added.
Simberg said the findings open the door to broader and safer applications of nanomedicine for diseases such as cancer, infections and genetic conditions.
“If we can manage the body’s response more effectively, we can improve access to these life-saving therapies for a wider group of patients,” said Simberg.
The collaborative study involved scientists from both the University of Colorado Anschutz Medical Campus, Cardiff University, and Newcastle University in the United Kingdom.
More information: Yue Li et al, Enhanced Immunocompatibility and Hemocompatibility of Nanomedicines Across Multiple Species Using Complement Pathway Inhibitors, Science Advances (2025). DOI: 10.1126/sciadv.adw1731. www.science.org/doi/10.1126/sciadv.adw1731
Journal information: Science Advances
Provided by CU Anschutz Medical Campus
News
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
